The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy
Abstract
Amiodarone, an iodine-containing drug used frequently in the treatment of cardiac arrhythmias and angina pectoris, has many effects on thyroid hormone metabolism, including decreasing the production of triiodothyronine (T3) and decreasing the clearance of thyroxine and reverse T3. These effects result in elevated serum thyroxine and reverse T3 concentrations and decreased serum T3 concentrations. In addition, iodine-induced hyperthyroidism or hypothyroidism may occur in patients chronically treated with amiodarone. This study is a retrospective analysis of the incidence of thyroid dysfunction in Lucca and Pisa, West Tuscany, Italy, and in Worcester, Massachusetts. Hyperthyroidism was a more frequent (9.6%) complication of amiodarone therapy in West Tuscany, where iodine intake is moderately low; hypothyroidism was more frequent (22%) in Worcester, where iodine intake is sufficient. In patients receiving chronic amiodarone therapy, clinically suspected hyperthyroidism is best confirmed by showing elevations in serum T3 or free T3 concentrations; hypothyroidism is best diagnosed by showing an elevated serum thyrotrophin concentration. Thyroid function should be carefully monitored in patients receiving amiodarone chronically, especially if they have goiter or Hashimoto's thyroiditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heger, J. J., Prystowsky, E. N., Jackman, W. M., Naccarelli, G. V., Warfel, K. A., Rinkenberger, R. L., & Zipes, D. P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109033051002 · Cited by 571
Clinical efficacy of amiodarone as an antiarrhythmic agent
Rosenbaum, M. B., Chiale, P. A., Halpern, M. S., Nau, G. J., Przybylski, J., Levi, R. J., Lázzari, J. O., & Elizari, M. V. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90807-9 · Cited by 566
The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle
SINGH, B. N., & WILLIAMS, E. M. V. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb09891.x · Cited by 553
Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 312
FRADKIN, J. E., & WOLFF, J. (1983) · Medicine · doi:10.1097/00005792-198301000-00001 · Cited by 293
WOLFF, J., CHAIKOFF, I. L., GOLDBERG, R. C., & MEIER, J. R. (1949) · Endocrinology · doi:10.1210/endo-45-5-504 · Cited by 292
Protein-Bound Iodine, Total Iodine, and Butanol-extractable Iodine by Partial Automation
Benotti, J., & Benotti, N. (1963) · Clinical Chemistry · doi:10.1093/clinchem/9.4.408 · Cited by 212
Pharmacokinetics of amiodarone after intravenous and oral administration
Andreasen, F., Agerb�k, H., Bjerregaard, P., & G�tzsche, H. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562807 · Cited by 200
Enhanced Susceptibility to Iodide Myxedema in Patients with Hashimoto's Disease
BRAVERMAN, L. E., INGBAR, S. H., VAGENAKIS, A. G., ADAMS, L., & MALOOF, F. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-32-4-515 · Cited by 184
Self-citationAmiodarone in Refractory Life-Threatening Ventricular Arrhythmias
Nademanee, K., Singh, B. N., HENDRICKSON, J., INTARACHOT, V., LOPEZ, B., FELD, G., Cannom, D. S., & Weiss, J. N. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-577 · Cited by 183
Cited by
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“Amiodarone-induced thyrotoxicosis (AIT) occurs in up to 6% of patients taking this medication in iodine-sufficient areas of the world (573–575) and in up to 10% in iodinedeficient areas, such as parts of Europe (576).”
BackgroundInfluentialGlobal epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Iodine deficiency and thyroid disorders
Zimmermann, M. B., & Boelaert, K. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70225-6 · Cited by 930
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Metadata
- Authors
- MARTINO, E., SAFRAN, M., AGHINI-LOMBARDI, F., RAJATANAVIN, R., LENZIARDI, M., FAY, M., PACCHIAROTTI, A., ARONIN, N., MACCHIA, E., HAFFAJEE, C., ODOGUARDI, L., LOVE, J., BIGALLI, A., BASCHIERI, L., PINCHERA, A., & BRAVERMAN, L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1984-07-01
- Volume
- 101
- Issue
- 1
- Pages
- 28-34
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2122875844
- Cited by
- 370
- References
- 26
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy. https://app.cochat.ai/papers/10.7326/0003-4819-101-1-28
- The paper
- MARTINO, E., SAFRAN, M., AGHINI-LOMBARDI, F., RAJATANAVIN, R., LENZIARDI, M., FAY, M., PACCHIAROTTI, A., ARONIN, N., MACCHIA, E., HAFFAJEE, C., ODOGUARDI, L., LOVE, J., BIGALLI, A., BASCHIERI, L., PINCHERA, A., & BRAVERMAN, L. (1984). Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-101-1-28
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.